GlassScriptPhysician profile
Michael James Wilkins
NPI 1417298597
$4,460.78
in general payments reported to CMS, 2019-2025
31 companies · $412 in 2025
The $412 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $286 · 2021: $482 · 2022: $463 · 2023: $1,992 · 2024: $474 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,297 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,297.46 |
| Travel and Lodging | $580.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,044.84 | 2019-2023 | Prophecy, Inbone, Invision |
| Horizon Therapeutics Plc | $426.17 | 2020-2023 | Krystexxa |
| Organogenesis INC. | $422.89 | 2020-2024 | Puraply |
| Abbvie INC. | $363.51 | 2021-2023 | Dalvance |
| Treace Medical Concepts, INC. | $357.06 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $344.81 | 2020-2025 | Nuzyra |
| Boston Scientific Corporation | $257.23 | 2019-2023 | |
| Convatec INC. | $182.84 | 2023-2024 | |
| Smith+Nephew, INC. | $145.64 | 2020-2025 | Collagenase Santyl, Renasys Touch, Grafix |
| Amgen INC. | $119.39 | 2024 | Krystexxa |
| Next Science LLC | $119.02 | 2023 | Blastx, Xperience, Surgx |
| Reprise Biomedical, INC. | $99.25 | 2023-2024 | Miro3d |
| Medtronic, INC. | $74.82 | 2023-2025 | Intellis Adaptivestim, Venaseal |
| Orthofix Medical, INC. | $56.55 | 2023-2025 | Physio-Stim |
| Melinta Therapeutics, LLC | $48.43 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $45.71 | 2019-2025 | Cmf |
| Kerecis Limited | $37.30 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kowa Pharmaceuticals America, INC. | $35.94 | 2023 | Seglentis |
| Grt US Holding, INC. | $34.59 | 2022 | |
| Globus Medical, INC. | $34.00 | 2025 | Senza |
| Depuy Synthes Sales INC. | $33.50 | 2023 | Motoband, Minibunion |
| Solventum Corporation | $30.60 | 2025 | 3m Cavilon, Activ.A.C. |
| Mimedx Group, INC. | $23.10 | 2025 | |
| Merck Sharp & Dohme LLC | $18.13 | 2019 | |
| Arthrex, INC. | $18.00 | 2023 | |
| Kci USA, INC. | $16.57 | 2020 | |
| Heron Therapeutics, INC. | $16.45 | 2021 | |
| Metric Medical Devices, INC. | $14.65 | 2020 | |
| Nabriva Therapeutics, Plc | $14.19 | 2021 | |
| Coastal Medical Technologies LLC | $13.47 | 2024 | |
| Fidia Pharma USA INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.